Each individual has more than 20 years of experience working within the clinical, scientific and commercial areas of the skin care market, at prestigious organisations. Joining co-founder and board chairman, Michael Kahn, Ph.D., the Broad Center for Regenerative Medicine and Stem Cell Research at USC's Keck School of Medicine, is Lawrence A. Rheins, Ph.D., who is taking the helm as president and CEO.
With him, as VP and chief science and medical officer is Mark Dahl, M.D., and Allison Wren, Ph.D. assumes the role of VP for product development. Leading the sales team is Michael Casanova, VP of sales.
"Makucell has a highly credible senior management team to launch the company and our revolutionary, proprietary, science-based products," comments Dr. Lawrence Rheins, Makucell's president and CEO. "Our initial studies on our skin care line have been overwhelmingly positive, and the first product users have given us enthusiastic praise with regard to our products' remarkable effectiveness."
Dr. Michael Kahn adds, "The members of Makucell's core team are all leaders in the commercial skin care business, scientific research and medical dermatology fields. Everyone on the team is an enthusiastic supporter of the technology platform and our science-based products. We are continuing to meticulously conduct studies, testing for efficacy, and look forward to reporting the near-term results."
